EP 0726777 A1 19960821 - PROKARYOTIC EXPRESSION OF MHC PROTEINS
Title (en)
PROKARYOTIC EXPRESSION OF MHC PROTEINS
Title (de)
Procarciotische Expression von MHC - Proteinen
Title (fr)
EXPRESSION PROCARYOTE DE PROTEINES DU CMH
Publication
Application
Priority
- US 9412231 W 19941025
- US 14357593 A 19931025
Abstract (en)
[origin: WO9511702A1] The present invention is directed to unglycosylated, prokaryotically-expressed MHC polypeptides, methods of producing these polypeptides, and complexes consisting essentially of an isolated MHC component and an antigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating deleterious immune responses, such as autoimmunity.
IPC 1-7
IPC 8 full level
A61K 9/127 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C07K 14/74 (2006.01); C12N 1/21 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12R 1/19 (2006.01)
CPC (source: EP KR)
A61K 39/385 (2013.01 - KR); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 14/70539 (2013.01 - EP); A61K 38/00 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9511702 A1 19950504; CA 2175089 A1 19950504; EP 0726777 A1 19960821; EP 0726777 A4 20020424; JP H09504432 A 19970506; KR 100369286 B1 20030723; KR 960705583 A 19961108
DOCDB simple family (application)
US 9412231 W 19941025; CA 2175089 A 19941025; EP 94932028 A 19941025; JP 51278094 A 19941025; KR 19960702120 A 19960425